Standout Papers
- Identification and Characterization of Metabolically Benign Obesity in Humans (2008)
- Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach (2012)
- Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications (2013)
- Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies (2018)
- Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance (2009)
- High Alanine Aminotransferase Is Associated With Decreased Hepatic Insulin Sensitivity and Predicts the Development of Type 2 Diabetes (2002)
- Obesity and impaired metabolic health in patients with COVID-19 (2020)
- Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans (2017)
- Causes, consequences, and treatment of metabolically unhealthy fat distribution (2020)
- The impact of insulin resistance on the kidney and vasculature (2016)
- Global pandemics interconnected — obesity, impaired metabolic health and COVID-19 (2021)
- Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study (2018)
- Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes (2021)
- The role of hepatokines in NAFLD (2023)
- Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment (2023)
- Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment (2024)
Immediate Impact
6 by Nobel laureates 8 from Science/Nature 109 standout
Citing Papers
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
2024 Standout
Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
Works of Norbert Stefan being referenced
Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
2021
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Norbert Stefan | 9529 | 7179 | 7443 | 333 | 22.8k | |
| Karen S.L. Lam | 8803 | 6010 | 7421 | 383 | 25.8k | |
| Ulf Smith | 8232 | 6687 | 11530 | 391 | 26.9k | |
| Paresh Dandona | 5975 | 8323 | 4958 | 493 | 24.5k | |
| Amalia Gastaldelli | 10395 | 10660 | 7618 | 345 | 24.5k | |
| Michael Stümvoll | 9056 | 7094 | 11582 | 574 | 31.0k | |
| Enzo Bonora | 8182 | 10824 | 4307 | 342 | 24.2k | |
| Michael Roden | 9569 | 8830 | 11968 | 683 | 31.5k | |
| José Manuel Fernández‐Real | 7164 | 3783 | 8241 | 497 | 25.9k | |
| Hannele Yki‐Järvinen | 13013 | 15966 | 9255 | 379 | 34.6k | |
| Fredrik Karpe | 4391 | 5276 | 6352 | 284 | 17.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...